UK just approve the Pfizer and BioNTech coronavirus vaccine for widespread use. BBC reports that “British regulator, the MHRA, says the jab, which offers up to 95% protection against Covid-19 illness, is safe for roll out next week.” Pfizer first reported that their mRNA-based COVID-19 vaccine was 90% effective against the coronavirus then later released an update that the vaccine is “95% effective against COVID-19 beginning 28 days after the first dose. UK government already…
Posts tagged as “BioNTech”
This is a press release by Pfizer and its partner BioNTech regarding the first results from Phase 3 clinical trial, which began last July 27 with 43,538 participants. Their mRNA-based vaccine candidate, BNT162b2, against COVID-19 has been found 90% effective in participants in their Phase 3 clinical trial. Pfizer’s COVID-19 vaccine is a 2-dose vaccine, which are applied in 7 days interval. Pfizer expect to supply up to 50 million vaccine doses by the end…